This bill aims to make the U.S. medical supply chain stronger and more reliable, especially during health emergencies. It lets the President make trade agreements with trusted countries to reduce or remove tariffs and other barriers on medical goods like drugs, devices, and their parts, when doing so would help U.S. public health and national security. These agreements can also push for clearer, faster rules across borders, protect intellectual property, and grow the number of suppliers so hospitals and patients can get what they need when demand spikes .

Congress must be notified 60 days before talks start, and it reviews each agreement. An agreement cannot take effect if Congress passes a disapproval resolution during the review period. After an agreement is in place, the U.S. Trade Representative must monitor partners and, if they don’t follow the rules, the President can pause benefits or take other steps to fix the problem .

Key points

• Who is affected: Patients, health care providers, and U.S. makers and buyers of medical goods. Trade partners that meet “trusted” standards are involved .
• What changes: Allows tariff cuts and other steps to speed up and secure medical supplies; encourages more suppliers, smoother regulations, and strong IP protections; requires monitoring and enforcement if a partner falls short .
• When: Before any talks begin, Congress gets 60 days’ notice; agreements only take effect after a review window without a disapproval vote .